Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10
![]() ![]() |
Song, Dae-Geun
(Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute)
Lee, Joo-Young (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Lee, Eun-Ha (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Jung, Sang-Hoon (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Nho, Chu-Won (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Cha, Kwang-Hyun (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Koo, Song-Yi (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) Pan, Cheol-Ho (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) |
1 | Zhang, L., Chen, W. and Li, X. (2008) A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS. Lett. 582, 1821-1828 DOI ScienceOn |
2 | Penning, T. M. (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer. Res. 11, 1687-1690 DOI ScienceOn |
3 | Lee, E. H., Song, D. G., Lee, J. Y., Pan, C. H., Um, B. H. and Jung, S. H. (2008) Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31, 1626-1630 DOI ScienceOn |
4 | Samoszuk, M., Tan, J. and Chorn, G. (2005) The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC. Complement. Altern. Med. 5, 5 DOI ScienceOn |
5 | Matsunaga, T., Endo, S., Soda, M., Zhao, H. T., El- abbani, O., Tajima, K. and Hara, A. (2009) Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis. Biochem. Biophys. Res. Commun. 389, 128-132 DOI ScienceOn |
6 | Lee, J. Y., Song, D. G,. Jung, S. H., Kim, J. H., Ahn, S. Y., Nho, C. W. and Pan, C. H. (2009) Inhibitory effects of Korean local plant extracts on AKR1B10. Korean J. Pharmacognosy. 40, 238-243 |
7 | Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D. F. and Cao, D. (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 284, 26742-26748 |
8 | Pan, C. H., Lee, J. Y., Song. D. G., Kim, J. H., Ahn, S. Y., Bae, D. S., Kim, Y. H. and Lee, J. K. (2009) Antioxidant and Aldo-keto reductase family 1 B10 inhibition activities of Korean local plant extracts. J. Appl. Biol. Chem. 52, 216-220 DOI ScienceOn |
9 | Young, R. J., Ewing, D. J. and Clarke, B. F. (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 32, 938-942 DOI ScienceOn |
10 | Spite, M., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A. and Srivastava, S. (2007) Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem. J. 405, 95-105 DOI PUBMED |
11 | Ma, J., Yan, R., Zu, X., Cheng, J. M., Rao, K., Liao, D. F. and Cao, D. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J. Biol. Chem. 283, 3418-3423 DOI PUBMED ScienceOn |
12 | Cao, D., Fan, S. T. and Chung, S. S. (1998) Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435 DOI ScienceOn |
13 | Scuric, Z., Stain, S. C., Anderson, W. F. and Hwang, J. J. (1998) New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology. 27, 943-950 DOI ScienceOn |
14 | Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M. and Cao, D. (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer. 121, 2301-2306 DOI ScienceOn |
15 | Moon, D. O., Kim, M. O., Choi, Y. H., Hyun, J. W., Chang, W. Y. and Kim, G. Y. (2010) Butein induces G(2)/phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett. 288, 204-213 DOI ScienceOn |
16 | Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., Ogawa, H., Hamakubo, T., Kodama, T. and Araki, Y. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer. 17, 1300-1306 DOI PUBMED |
17 | Robison, W. G., Jr., Nagata, M., Laver, N., Hohman, T. C. and Kinoshita, J. H. (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest. Ophthalmol. Vis. Sci. 30, 2285-2292 PUBMED |
18 | Dunlop, M. (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. Suppl. 77, S3-12 DOI ScienceOn |
19 | Frank, R. N., Keirn, R. J., Kennedy, A. and Frank, K. W. (1983) Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil. Invest. Ophthalmol. Vis. Sci. 24, 1519-1524 PUBMED |
20 | Endo, S., Matsunaga, T., Mamiya, H., Ohta, C., Soda, M., Kitade, Y., Tajima, K., Zhao, H. T., El-Kabbani, O. and Hara, A. (2009) Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Arch. Biochem. Biophys. 487, 1-9 DOI ScienceOn |
21 | Fukumoto, S., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., Iwanari, H., Hironaka, M., Ishikawa, Y., Niki, T., Sohara, Y., Kodama, T., Nishimura, M., Fukayama, M., Dosaka-Akita, H. and Aburatani, H. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' nonsmall cell lung carcinomas. Clin. Cancer. Res. 11, 1776-1785 DOI ScienceOn |
22 | Sato, S. and Kador, P. F. (1990) Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40, 1033-1042 DOI ScienceOn |
23 | Lee, J. Y., Song, D. G., Lee, E. H., Jung, S. H., Nho, C. W., Cha, K. H. and Pan, C. H. (2009) Inhibitory effects of 3,5-O-dicaffeoyl-epi-quinic acid from Gymnaster koraiensis on AKR1B10. J. Korean. Soc. Appl. Biol. Chem. 52, 731-734 DOI ScienceOn |
24 | Crosas, B., Hyndman, D. J., Gallego, O., Martras, S., Pares, X., Flynn, T. G. and Farres, J. (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J. 373, 973-979 DOI ScienceOn |
25 | Gallego, O., Ruiz, F. X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farres, J., Fita, I. and Pares, X. (2007) Structural basis for the high alltrans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U.S.A. 104, 20764-20769 DOI ScienceOn |
26 | Jung, C. H., Kim, J. H., Hong, M. H., Seog, H. M., Oh, S. H., Lee, P. J., Kim, G. J., Kim, H. M., Um, J. Y. and Ko, S. G. (2007) Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NFappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 110, 490-497 DOI ScienceOn |
27 | de la Fuente, J. A. and Manzanaro, S. (2003) Aldose reductase inhibitors from natural sources. Nat. Prod. Rep. 20, 243-251 DOI ScienceOn |
![]() |